Pulmovant旗下药物Mosliciguat获得日本孤儿药认定,用于治疗间质性肺病相关肺动脉高压

美股速递
Sep 04

Pulmovant宣布,其药物Mosliciguat已获得日本监管部门颁发的孤儿药认定,该药物用于治疗间质性肺病相关肺动脉高压(Ph-Ild)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10